These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 30293331)

  • 61. Methotrexate for rheumatoid arthritis: a guide from Canada.
    Verstappen SM; Hyrich KL
    J Rheumatol; 2010 Jul; 37(7):1374-6. PubMed ID: 20595290
    [No Abstract]   [Full Text] [Related]  

  • 62. When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis.
    Fraenkel L; Miller AS; Clayton K; Crow-Hercher R; Hazel S; Johnson B; Rott L; White W; Wiedmeyer C; Montori VM; Singh JA; Nowell WB
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):26-35. PubMed ID: 26545701
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Rheumatic diseases in pregnancy].
    Märker-Hermann E; Bauer H; Gromnica-Ihle E
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2410-4. PubMed ID: 18988134
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evidence-based recommendations for treatment with methotrexate in rheumatic disorders.
    Madsen OR; Faurschou M; Loft AG; Sørensen IJ; Knudsen JB; Baslund B; Hansen A; Hansen MS; Østergaard M
    Dan Med Bull; 2010 Oct; 57(10):A4190. PubMed ID: 21040680
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Implementation and use of biosimilars in the therapy of inflammatory rheumatic diseases: Statement of the German Society of Rheumatology].
    Lorenz HM; Braun J; Krüger K; Schneider M
    Z Rheumatol; 2014 Nov; 73(9):784-6. PubMed ID: 25373548
    [No Abstract]   [Full Text] [Related]  

  • 66. Achieving consensus on an algorithm for the treatment of rheumatoid arthritis with methotrexate.
    Ambrose RF; Moreland LW; Kendall LG; Brown S; Koopman WJ; Alarcón GS
    Arthritis Care Res; 1990 Mar; 3(1):53-7. PubMed ID: 2285740
    [No Abstract]   [Full Text] [Related]  

  • 67. Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotrexate and interferon.
    Nissen MJ; Fontanges E; Allam Y; Zoulim F; Trépo C; Miossec P
    Rheumatology (Oxford); 2005 Aug; 44(8):1016-20. PubMed ID: 15855185
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Potential effects of a national consensus statement on optimal treatment of early rheumatoid arthritis in Ontario.
    Bernatsky S; Paterson M; Thorne C; Cividino A; Pope J; Hux J; Bombardier C;
    Scand J Rheumatol; 2009; 38(5):390-1. PubMed ID: 19579090
    [No Abstract]   [Full Text] [Related]  

  • 69. Tumor necrosis factor alpha inhibitors and methotrexate: implications for deployed personnel.
    Martin JJ
    Aviat Space Environ Med; 2005 Dec; 76(12):1162-6. PubMed ID: 16370267
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Current "off label use" of methotrexate for chronic inflammatory rheumatic diseases].
    Briem S; Lorenz HM
    Z Rheumatol; 2011 Feb; 70(2):123-8. PubMed ID: 21267732
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lactation and Management of Postpartum Disease.
    Bermas BL
    Rheum Dis Clin North Am; 2017 May; 43(2):249-262. PubMed ID: 28390567
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Emerging issues in pharmacological management of rheumatoid arthritis: results of a national needs assessment survey identifying practice variations for the development of Canadian Rheumatology Association clinical practice recommendations.
    Bykerk VP; Schieir O; Akhavan P; Hazlewood GS; Cheng CK; Bombardier C
    J Rheumatol; 2012 Aug; 39(8):1555-8. PubMed ID: 21885494
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Proceedings of the 5th annual perspectives in rheumatic diseases.
    Furst DE; Mandell B; Calabrese LH; Cather JC; Clauw DJ; Deodhar A; Kremer JM; Lewiecki EM; McMahon M; Ritchlin CT
    Semin Arthritis Rheum; 2013 Dec; 43(3):416-9. PubMed ID: 24326035
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases.
    Manolis AS; Tzioufas AG
    Curr Vasc Pharmacol; 2020; 18(6):533-537. PubMed ID: 32693768
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Advances in the management of rheumatoid arthritis.
    Dale J
    Scott Med J; 2015 Aug; 60(3):108-14. PubMed ID: 26122283
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [2018 Chinese expert-based consensus statement regarding the diagnosis and treatment of interstitial lung disease associated with connective tissue diseases].
    ;
    Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):558-565. PubMed ID: 30060326
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients].
    Gómez Reino J; Loza E; Andreu JL; Balsa A; Batlle E; Cañete JD; Collantes Estévez E; Fernández Carballido C; Fernández Sueiro JL; García de Vicuña R; González-Álvaro I; González Fernández C; Juanola X; Linares LF; Marenco JL; Martín Mola E; Moreno Ramos M; Mulero Mendoza J; Muñoz Fernández S; Queiro R; Richi Alberti P; Sanz J; Tornero Molina J; Zarco Montejo P; Carmona L;
    Reumatol Clin; 2011; 7(5):284-98. PubMed ID: 21925444
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Pharmacological management of rheumatoid arthritis: the state of the art and the future perspective].
    Kameda H; Takeuchi T
    Nihon Rinsho; 2013 Jul; 71(7):1166-71. PubMed ID: 23961662
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Quality Indicators for Evaluating the Health Care of Patients with Rheumatoid Arthritis: a Korean Expert Consensus.
    Seo MR; Kim G; Moon KW; Sung YK; Yoo JJ; Yoon CH; Lee EB; Lee J; Kang EH; Kim H; Park EJ; Uhm WS; Lee MS; Lee SW; Choi BY; Hong SJ; Baek HJ
    J Korean Med Sci; 2021 May; 36(17):e109. PubMed ID: 33942576
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus.
    Gossec L; Molto A; Romand X; Puyraimond-Zemmour D; Lavielle M; Beauvais C; Senbel E; Flipo RM; Pouplin S; Richez C; Saraux A; Mézières M; Gutermann L; Gaudin P; Wendling D; Dougados M
    Joint Bone Spine; 2019 Jan; 86(1):13-19. PubMed ID: 30243782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.